Descriptive Epidemiology of COVID-19 Deaths during the First Wave of Pandemic in India: A Single-center Experience.

IF 1.5
Prakash Tendulkar, Pragya Pandey, Prasan K Panda, Ajeet S Bhadoria, Poorvi Kulshreshtha
{"title":"Descriptive Epidemiology of COVID-19 Deaths during the First Wave of Pandemic in India: A Single-center Experience.","authors":"Prakash Tendulkar,&nbsp;Pragya Pandey,&nbsp;Prasan K Panda,&nbsp;Ajeet S Bhadoria,&nbsp;Poorvi Kulshreshtha","doi":"10.5005/jp-journals-10071-24085","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>With the looming threat of recurrent waves of coronavirus disease-2019 (COVID-19) in the presence of mutated strains, it is of paramount importance to understand the demographic and clinical attributes of COVID-19 related mortalities in each pandemic wave. This could help policy makers, public health experts, and clinicians to better plan preventive and management strategies to curb COVID-19 related mortality.</p><p><strong>Materials and methods: </strong>This was a hospital record-based, retrospective cross-sectional descriptive study, at a tertiary care hospital in Rishikesh, India. The study included all deceased patients between March 2020 and January 2021 (first wave) who had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcription polymerase chain reaction (RT-PCR) and were hospitalized. The study was done to describe demography, clinical presentation, laboratory parameters, treatment given, and associated complications of all COVID-19 deaths.</p><p><strong>Result: </strong>Out of 424 mortalities, 298 (70.38%) were males and 126 (29.62%) were females. Mean age of patients was 55.85 ± 16.24 years, out of which 19.5% were less than 45 years old, 33.6% were 45-60 years old, and 41.8% were more than 60 years old. Comorbidity in the form of type II diabetes mellitus was present in 41.4% [95% CI (41.4-51.1)], hypertension in 39.8% [95% CI (35.1-44.6)], and coronary artery disease (CAD) in 15.2% [95% CI (11.8-18.8)]. At the time of presentation, shortness of breath was present in 73.6% [95% CI (69.1-77.7)], fever in 64.92% [95% CI (60.1-69.4)], and cough in 46.1%, [95% CI (41.1-50.8)]. Deranged laboratory parameters were lymphopenia in 90.2% [95% CI (86.8-92.7)], transaminitis in 59.7% [95% CI (54.8-64.3)], and hypercreatinemia in 37.7% [95% CI (33.1-42.5)]. Complications manifested were acute respiratory distress syndrome (ARDS) in 78.3% [95% CI (74-82.1)] and shock in 54.7% [95% CI (49.8-59.5)]. Median time duration between onset of symptom and hospital admission was 5 days (interquartile range (IQR) = 3-5 days) and median length of hospital stay was 9 days (IQR = 4-14 days).</p><p><strong>Conclusion: </strong>During the first pandemic wave, COVID-19 related mortality was 2.37 times higher among males, 2.14 times in the age group >60 than <45 years. The most common associated comorbidities (>40%) were type II diabetes mellitus and hypertension. The most common associated symptoms (>60%) were shortness of breath and fever. Lymphopenia was seen in >90% cases while liver involvement in 60% and kidney in 38% cases. Median hospital stay was doubled the prehospital illness.</p><p><strong>How to cite this article: </strong>Tendulkar P, Pandey P, Panda PK, Bhadoria AS, Kulshreshtha P. Descriptive Epidemiology of COVID-19 Deaths during the First Wave of Pandemic in India: A Single-center Experience. Indian J Crit Care Med 2022;26(1):71-75.</p>","PeriodicalId":520643,"journal":{"name":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","volume":" ","pages":"71-75"},"PeriodicalIF":1.5000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8a/0c/ijccm-26-71.PMC8783237.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5005/jp-journals-10071-24085","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: With the looming threat of recurrent waves of coronavirus disease-2019 (COVID-19) in the presence of mutated strains, it is of paramount importance to understand the demographic and clinical attributes of COVID-19 related mortalities in each pandemic wave. This could help policy makers, public health experts, and clinicians to better plan preventive and management strategies to curb COVID-19 related mortality.

Materials and methods: This was a hospital record-based, retrospective cross-sectional descriptive study, at a tertiary care hospital in Rishikesh, India. The study included all deceased patients between March 2020 and January 2021 (first wave) who had tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by reverse transcription polymerase chain reaction (RT-PCR) and were hospitalized. The study was done to describe demography, clinical presentation, laboratory parameters, treatment given, and associated complications of all COVID-19 deaths.

Result: Out of 424 mortalities, 298 (70.38%) were males and 126 (29.62%) were females. Mean age of patients was 55.85 ± 16.24 years, out of which 19.5% were less than 45 years old, 33.6% were 45-60 years old, and 41.8% were more than 60 years old. Comorbidity in the form of type II diabetes mellitus was present in 41.4% [95% CI (41.4-51.1)], hypertension in 39.8% [95% CI (35.1-44.6)], and coronary artery disease (CAD) in 15.2% [95% CI (11.8-18.8)]. At the time of presentation, shortness of breath was present in 73.6% [95% CI (69.1-77.7)], fever in 64.92% [95% CI (60.1-69.4)], and cough in 46.1%, [95% CI (41.1-50.8)]. Deranged laboratory parameters were lymphopenia in 90.2% [95% CI (86.8-92.7)], transaminitis in 59.7% [95% CI (54.8-64.3)], and hypercreatinemia in 37.7% [95% CI (33.1-42.5)]. Complications manifested were acute respiratory distress syndrome (ARDS) in 78.3% [95% CI (74-82.1)] and shock in 54.7% [95% CI (49.8-59.5)]. Median time duration between onset of symptom and hospital admission was 5 days (interquartile range (IQR) = 3-5 days) and median length of hospital stay was 9 days (IQR = 4-14 days).

Conclusion: During the first pandemic wave, COVID-19 related mortality was 2.37 times higher among males, 2.14 times in the age group >60 than <45 years. The most common associated comorbidities (>40%) were type II diabetes mellitus and hypertension. The most common associated symptoms (>60%) were shortness of breath and fever. Lymphopenia was seen in >90% cases while liver involvement in 60% and kidney in 38% cases. Median hospital stay was doubled the prehospital illness.

How to cite this article: Tendulkar P, Pandey P, Panda PK, Bhadoria AS, Kulshreshtha P. Descriptive Epidemiology of COVID-19 Deaths during the First Wave of Pandemic in India: A Single-center Experience. Indian J Crit Care Med 2022;26(1):71-75.

Abstract Image

Abstract Image

Abstract Image

印度第一波大流行期间COVID-19死亡的描述性流行病学:单中心经验。
背景:在存在突变株的情况下,随着冠状病毒病-2019 (COVID-19)复发波的威胁迫在眉睫,了解每波大流行中COVID-19相关死亡的人口学和临床属性至关重要。这可以帮助决策者、公共卫生专家和临床医生更好地规划预防和管理战略,以遏制与COVID-19相关的死亡率。材料和方法:这是一项基于医院记录的回顾性横断面描述性研究,在印度里希凯什的一家三级保健医院进行。该研究包括2020年3月至2021年1月(第一波)期间通过逆转录聚合酶链反应(RT-PCR)检测出严重急性呼吸综合征冠状病毒2 (SARS-CoV-2)阳性并住院的所有死亡患者。该研究描述了所有COVID-19死亡的人口学、临床表现、实验室参数、给予的治疗和相关并发症。结果:424例死亡中,男性298例(70.38%),女性126例(29.62%)。患者平均年龄55.85±16.24岁,其中45岁以下19.5%,45-60岁33.6%,60岁以上41.8%。合并II型糖尿病的患者占41.4% [95% CI(41.4-51.1)],高血压患者占39.8% [95% CI(35.1-44.6)],冠状动脉疾病(CAD)患者占15.2% [95% CI(11.8-18.8)]。在就诊时,73.6% [95% CI(69.1-77.7)]出现呼吸急促,64.92% [95% CI(60.1-69.4)]出现发热,46.1% [95% CI(41.1-50.8)]出现咳嗽。紊乱的实验室参数为淋巴细胞减少(90.2%)[95% CI(88.8 -92.7)],转氨炎(59.7%)[95% CI(54.8-64.3)],高肌酐血症(37.7%)[95% CI(33.1-42.5)]。并发症表现为急性呼吸窘迫综合征(ARDS)占78.3% [95% CI(74 ~ 82.1)],休克占54.7% [95% CI(49.8 ~ 59.5)]。出现症状至入院的中位时间间隔为5天(四分位数间距(IQR) = 3 ~ 5天),中位住院时间为9天(IQR = 4 ~ 14天)。结论:在第一波流行期间,男性COVID-19相关死亡率为2.37倍,60岁以上年龄组为2.14倍(占40%),为II型糖尿病和高血压。最常见的相关症状(>60%)是呼吸急促和发烧。淋巴细胞减少>90%,累及肝脏60%,累及肾脏38%。住院时间中位数是院前疾病的两倍。Tendulkar P, Pandey P, Panda PK, Bhadoria AS, Kulshreshtha P.印度第一波COVID-19大流行期间死亡的描述性流行病学:单中心经验。中华检验医学杂志;2009;26(1):71-75。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书